Literature DB >> 2249376

Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine.

G A Kyerematen1, M L Morgan, B Chattopadhyay, J D deBethizy, E S Vesell.   

Abstract

The disposition of a single intravenous dose of 14C-nicotine was investigated in six cigarette smokers and six nonsmokers. Plasma and urinary elimination of both nicotine and cotinine was faster in smokers than in nonsmokers. In the urine of both smokers and nonsmokers, we identified nicotine and eight metabolites, including two new metabolites: metabolite A (3-hydroxycotinine glucuronide) and metabolite G (demethylcotinine delta 2',3'-enamine). Metabolites A and G were of particular interest because, in smokers, they both persisted longer than cotinine. This property renders them more sensitive than cotinine as potential indicators of passive exposure to cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249376     DOI: 10.1038/clpt.1990.208

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

1.  A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine.

Authors:  Joshua T Ayers; Rui Xu; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2005-10-31       Impact factor: 4.009

2.  High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.

Authors:  P A Fredrickson; R D Hurt; G M Lee; L Wingender; I T Croghan; G Lauger; L Gomez-Dahl; K P Offord
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 3.  Aspects of the oxidative metabolism of nicotine.

Authors:  G B Neurath
Journal:  Clin Investig       Date:  1994-02

4.  Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.

Authors:  Jennifer B Treweek; Tobin J Dickerson; Kim D Janda
Journal:  Acc Chem Res       Date:  2009-05-19       Impact factor: 22.384

5.  The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.

Authors:  A Joseph Bloom; Linda B von Weymarn; Maribel Martinez; Laura J Bierut; Alison Goate; Sharon E Murphy
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

Review 6.  Chemical analyses as validators in smoking cessation programs.

Authors:  D D Gilbert
Journal:  J Behav Med       Date:  1993-06

7.  Lack of effect of cimetidine on cigarette smoking.

Authors:  R Bendayan; G Kennedy; R C Frecker; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  A physiologically based pharmacokinetic model for nicotine and cotinine in man.

Authors:  D E Robinson; N J Balter; S L Schwartz
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

Review 9.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

10.  The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain.

Authors:  Joseph R Holtman; Peter A Crooks; Jaime K Johnson-Hardy; Elzbieta P Wala
Journal:  Pharmacol Biochem Behav       Date:  2009-10-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.